Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!

Thrombophilia and hemostatic activation common to most hemolytic conditions are likely explained by the very feature they all share, intravascular hemolysis. See related article on page 20.

[1]  C. Moore,et al.  Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension , 2008, Haematologica.

[2]  M. Gladwin,et al.  Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. , 2007, Blood.

[3]  M. Cairo,et al.  Pulmonary hypertension in sickle cell disease. , 2007, Clinical advances in hematology & oncology : H&O.

[4]  Peter J. Munson,et al.  Amplified Expression Profiling of Platelet Transcriptome Reveals Changes in Arginine Metabolic Pathways in Patients With Sickle Cell Disease , 2007, Circulation.

[5]  A. Cooper,et al.  Tissue factor and nitric oxide: a controversial relationship! , 2007, Journal of Thrombosis and Thrombolysis.

[6]  M. Gladwin,et al.  Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cytoprotection, and vasodilation. , 2006, American journal of physiology. Heart and circulatory physiology.

[7]  M. Gladwin,et al.  Cerebrovascular disease associated with sickle cell pulmonary hypertension , 2006, American journal of hematology.

[8]  K. Ataga,et al.  Biologically Active CD40 Ligand Is Elevated in Sickle Cell Anemia: Potential Role for Platelet-Mediated Inflammation , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[9]  R. Bach,et al.  Tissue factor encryption. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[10]  M. Gladwin,et al.  Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. , 2005, The Journal of clinical investigation.

[11]  Mark T Gladwin,et al.  Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. , 2005, Blood.

[12]  L. Farrer,et al.  Hemolysis-associated Priapism in Sickle Cell Disease , 2005 .

[13]  Malte Kelm,et al.  The emerging biology of the nitrite anion , 2005, Nature chemical biology.

[14]  M. Gladwin,et al.  The Reaction between Nitrite and Deoxyhemoglobin , 2005, Journal of Biological Chemistry.

[15]  Stanley L Hazen,et al.  Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. , 2005, JAMA.

[16]  M. Gladwin,et al.  The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. , 2005, JAMA.

[17]  M. Tsironi,et al.  Cardiovascular effects of splenomegaly and splenectomy in β-thalassemia , 2005, Annals of Hematology.

[18]  L. Farrer,et al.  Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia , 2005, British journal of haematology.

[19]  D. Jardine,et al.  Delayed pulmonary hypertension following splenectomy for congenital spherocytosis , 2004, Internal medicine journal.

[20]  Kuypers Fa,et al.  The role of phosphatidylserine in recognition and removal of erythrocytes. , 2004 .

[21]  K. Ataga,et al.  Hypercoagulability in sickle cell disease: a curious paradox. , 2003, The American journal of medicine.

[22]  M. Gladwin,et al.  Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation , 2003, Nature Medicine.

[23]  V. Andrieu,et al.  Priapism in a patient with unstable hemoglobin: Hemoglobin Köln , 2003, American journal of hematology.

[24]  S. Chuncharunee,et al.  Pulmonary Arterial Hypertension in Previously Splenectomized Patients with β-Thalassemic Disorders , 2003 .

[25]  M. Gladwin,et al.  Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway. , 2003, American journal of respiratory and critical care medicine.

[26]  Mark T Gladwin,et al.  Hemoglobin and the paracrine and endocrine functions of nitric oxide. , 2003, The New England journal of medicine.

[27]  M. Humbert,et al.  An Extreme Consequence of Splenectomy in Dehydrated Hereditary Stomatocytosis: Gradual Thrombo‐embolic Pulmonary Hypertension and Lung–Heart Transplantation , 2003, Hemoglobin.

[28]  P. Adegboyega,et al.  Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. , 2002, Human pathology.

[29]  R. Adams,et al.  Sickle cell disease: The neurological complications , 2002, Annals of neurology.

[30]  M. Hughson,et al.  Pulmonary thrombotic arteriopathy in patients with sickle cell disease. , 2001, Archives of pathology & laboratory medicine.

[31]  J. Liao,et al.  Modulation of nitric oxide bioavailability by erythrocytes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Chou,et al.  Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency , 2001, American journal of hematology.

[33]  J. Eckman,et al.  Thrombogenesis in sickle cell disease. , 2001, The Journal of laboratory and clinical medicine.

[34]  M. Stuart,et al.  Hemostatic Alterations in Sickle Cell Disease: Relationships to Disease Pathophysiology , 2001, Pediatric pathology & molecular medicine.

[35]  A. Morelli,et al.  IL-1β Converting Enzyme Is a Target for Nitric Oxide-Releasing Aspirin: New Insights in the Antiinflammatory Mechanism of Nitric Oxide-Releasing Nonsteroidal Antiinflammatory Drugs , 2000, The Journal of Immunology.

[36]  F. Kirkham,et al.  Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia , 2000, British journal of haematology.

[37]  J. Liao,et al.  Erythrocytes Possess an Intrinsic Barrier to Nitric Oxide Consumption* , 2000, The Journal of Biological Chemistry.

[38]  P. Williamson,et al.  Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. , 1999, The Journal of laboratory and clinical medicine.

[39]  N. Wandersee,et al.  Thrombosis in heritable hemolytic disorders. , 1999, Current opinion in hematology.

[40]  H. Gerlach,et al.  Nitric oxide inhibits tissue factor synthesis, expression and activity in human monocytes by prior formation of peroxynitrite , 1998, Intensive Care Medicine.

[41]  I. Megson,et al.  Diffusion of nitric oxide and scavenging by blood in the vasculature. , 1998, Biochimica et biophysica acta.

[42]  D. Payen,et al.  Impact of inhaled nitric oxide on platelet aggregation and fibrinolysis in rats with endotoxic lung injury. Role of cyclic guanosine 5'-monophosphate. , 1998, American journal of respiratory and critical care medicine.

[43]  Scott T. Miller,et al.  Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. , 1998, The New England journal of medicine.

[44]  C. Moertel,et al.  Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. , 1998, Blood.

[45]  K. Kerr,et al.  Successful pulmonary thromboendarterectomy in two patients with sickle cell disease. , 1998, American journal of respiratory and critical care medicine.

[46]  RoyG. Smith,et al.  Hereditary spherocytosis, thrombocytosis, and chronic pulmonary emboli: A case report and review of the literature , 1998, American journal of hematology.

[47]  G. Stewart,et al.  THROMBO‐EMBOLIC DISEASE AFTER SPLENECTOMY FOR HEREDITARY STOMATOCYTOSIS , 1996, British journal of haematology.

[48]  A. Schroit,et al.  Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells. , 1994, The Journal of biological chemistry.

[49]  P. Heller,et al.  Pulmonary hypertension in paroxysmal nocturnal hemoglobinuria. , 1992, Chest.

[50]  F. Dore,et al.  Priapism in thalassemia intermedia. , 1991, Haematologica.

[51]  P. Macchia,et al.  Thalassemia intermedia and recurrent priapism following splenectomy. , 1990, Haematologica.

[52]  S. Moncada,et al.  ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM , 1987, The Lancet.

[53]  S. Moncada,et al.  Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets , 1987, British journal of pharmacology.

[54]  K. R. Rao,et al.  Priapism and thalassaemia intermedia , 1986, The British journal of surgery.

[55]  N. Jackson,et al.  Recurrent priapism following splenectomy for thalassaemia intermedia , 1986, The British journal of surgery.

[56]  R. Schwartz,et al.  Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes. , 1985, The Journal of clinical investigation.

[57]  J. Olson,et al.  The rate of oxygen uptake by human red blood cells. , 1979, The Journal of biological chemistry.

[58]  M. Gladwin,et al.  Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. , 2007, Blood reviews.

[59]  M. Tsironi,et al.  Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia. , 2005, Annals of hematology.

[60]  F. Kuypers,et al.  The role of phosphatidylserine in recognition and removal of erythrocytes. , 2004, Cellular and molecular biology.

[61]  S. Chuncharunee,et al.  Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders. , 2003, International journal of hematology.

[62]  A. Eldor,et al.  The hypercoagulable state in thalassemia. , 2002, Blood.

[63]  M. Gladwin,et al.  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease , 2002, Nature Medicine.

[64]  B. Jude,et al.  Acute priapism in a patient with unstable hemoglobin Perth and Factor V Leiden under effective oral anticoagulant therapy. , 2001, The hematology journal : the official journal of the European Haematology Association.

[65]  Y. Asada,et al.  Pulmonary microthromboembolism by injection of sonicated autologous blood in rabbits with splenic artery ligations. , 1997, The Southeast Asian journal of tropical medicine and public health.

[66]  D. Cowick,et al.  Therapeutic splenectomy. , 1975, The American surgeon.